TRIAMTERENE AND HYDROCHLOROTHIAZIDE

TRIAMTERENE AND HYDROCHLOROTHIAZIDE was reported 6140 times

TRIAMTERENE AND HYDROCHLOROTHIAZIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD PROLACTIN DECREASED 4 0.0229
1 PATHOLOGICAL GAMBLING 13 0.0078
2 INTESTINAL FUNCTIONAL DISORDER 4 0.0063
3 ENDOCRINE OPHTHALMOPATHY 5 0.0058
4 ELECTROCARDIOGRAM ST-T CHANGE 4 0.0056
5 ANAEMIA OF CHRONIC DISEASE 5 0.0055
6 CERUMEN IMPACTION 5 0.0055
7 ACQUIRED HAEMOPHILIA 5 0.0050
8 GINGIVAL INFECTION 4 0.0050
9 CATHETER RELATED INFECTION 5 0.0049
10 CARDIAC STRESS TEST ABNORMAL 4 0.0048
11 LEFT ATRIAL DILATATION 6 0.0047
12 KYPHOSIS 7 0.0040
13 IMMUNOGLOBULINS DECREASED 5 0.0036
14 MENISCUS LESION 5 0.0036
15 BILIARY DYSKINESIA 6 0.0035
16 IMPETIGO 5 0.0034
17 ORAL INTAKE REDUCED 8 0.0033
18 ESSENTIAL HYPERTENSION 6 0.0033
19 INTERVERTEBRAL DISC OPERATION 4 0.0032
20 HYPERTENSIVE HEART DISEASE 6 0.0032
21 FRACTURED COCCYX 4 0.0032
22 BLOOD CHLORIDE DECREASED 8 0.0031
23 CARDIOACTIVE DRUG LEVEL INCREASED 4 0.0030
24 COLONIC POLYP 5 0.0030
25 THERAPEUTIC AGENT TOXICITY 10 0.0030
26 THROMBOPHLEBITIS SUPERFICIAL 9 0.0030
27 EROSIVE OESOPHAGITIS 5 0.0029
28 CERVICAL SPINAL STENOSIS 5 0.0029
29 PRE-EXISTING CONDITION IMPROVED 18 0.0029
30 BUNDLE BRANCH BLOCK LEFT 12 0.0028
31 BLOOD ELECTROLYTES DECREASED 4 0.0028
32 HEART INJURY 7 0.0028
33 VENTRICULAR HYPERTROPHY 7 0.0028
34 HYPOVOLAEMIA 15 0.0026
35 ELECTRIC SHOCK SENSATION 7 0.0025
36 THYROID FUNCTION TEST ABNORMAL 10 0.0024
37 DEMENTIA ALZHEIMER'S TYPE 4 0.0024
38 HYPERPARATHYROIDISM SECONDARY 6 0.0024
39 NEPHROGENIC ANAEMIA 11 0.0024
40 EYE CONTUSION 5 0.0024
41 LEFT VENTRICULAR HYPERTROPHY 10 0.0023
42 REACTION TO DRUG EXCIPIENTS 5 0.0023
43 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 5 0.0023
44 HYPERPHAGIA 9 0.0023
45 DIABETIC NEUROPATHY 11 0.0022
46 EAR CONGESTION 6 0.0022
47 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 9 0.0022
48 LOBAR PNEUMONIA 4 0.0022
49 LICHEN PLANUS 5 0.0022
50 BLOOD BICARBONATE DECREASED 4 0.0021
51 LUNG NEOPLASM 9 0.0021
52 INFLAMMATORY MARKER INCREASED 10 0.0020
53 MEDICATION RESIDUE 5 0.0019
54 POSTMENOPAUSAL HAEMORRHAGE 5 0.0019
55 SLEEP APNOEA SYNDROME 36 0.0019
56 GASTRIC BYPASS 4 0.0018
57 BLOOD POTASSIUM DECREASED 55 0.0018
58 TYPE 1 DIABETES MELLITUS 11 0.0018
59 SPINAL OSTEOARTHRITIS 16 0.0018
60 HAIR DISORDER 15 0.0018
61 RED BLOOD CELL COUNT INCREASED 5 0.0018
62 TONGUE ULCERATION 6 0.0018
63 DISTRIBUTIVE SHOCK 4 0.0018
64 CANDIDIASIS 7 0.0017
65 NERVE COMPRESSION 16 0.0017
66 HAIR TEXTURE ABNORMAL 23 0.0017
67 CAROTID ARTERY STENOSIS 6 0.0017
68 HANGOVER 6 0.0017
69 SPINAL COLUMN STENOSIS 8 0.0017
70 HAIR COLOUR CHANGES 21 0.0017
71 HAEMORRHAGIC DIATHESIS 6 0.0017
72 BLOOD PRESSURE INADEQUATELY CONTROLLED 10 0.0017
73 BLOOD PHOSPHORUS DECREASED 6 0.0016
74 HYPERKERATOSIS 9 0.0016
75 DIASTOLIC DYSFUNCTION 5 0.0016
76 DEVICE INFUSION ISSUE 4 0.0016
77 BLOOD BLISTER 5 0.0016
78 PARANASAL SINUS HYPERSECRETION 6 0.0016
79 BLOOD UREA INCREASED 26 0.0016
80 ANOREXIA 20 0.0016
81 GLOMERULAR FILTRATION RATE DECREASED 19 0.0015
82 HERNIA REPAIR 4 0.0015
83 INFUSION SITE HAEMORRHAGE 5 0.0015
84 RENAL FAILURE ACUTE 64 0.0015
85 AZOTAEMIA 6 0.0015
86 ANIMAL BITE 4 0.0015
87 ANGIONEUROTIC OEDEMA 4 0.0015
88 STRESS FRACTURE 8 0.0015
89 SUPRAVENTRICULAR EXTRASYSTOLES 5 0.0015
90 ACTIVITIES OF DAILY LIVING IMPAIRED 29 0.0015
91 AORTIC STENOSIS 5 0.0014
92 RENAL FAILURE CHRONIC 11 0.0014
93 DIABETIC COMA 4 0.0014
94 EXOSTOSIS 13 0.0014
95 LIP PAIN 4 0.0014
96 FACIAL BONES FRACTURE 5 0.0014
97 PATHOLOGICAL FRACTURE 7 0.0014
98 URINE OUTPUT DECREASED 12 0.0014
99 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 7 0.0014
100 ARTERIOSCLEROSIS CORONARY ARTERY 9 0.0014
101 STOMACH DISCOMFORT 7 0.0014
102 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
103 LOWER GASTROINTESTINAL HAEMORRHAGE 10 0.0014
104 HYPONATRAEMIA 76 0.0013
105 INFUSION SITE REACTION 4 0.0013
106 POLYARTHRITIS 7 0.0013
107 BLOOD SODIUM DECREASED 25 0.0013
108 BURSITIS 16 0.0013
109 OSTEOPENIA 20 0.0013
110 MICTURITION URGENCY 15 0.0013
111 HIATUS HERNIA 17 0.0013
112 OEDEMA PERIPHERAL 159 0.0013
113 EYE OPERATION 6 0.0013
114 MENISCUS INJURY 8 0.0013
115 BLOOD PRESSURE DIASTOLIC INCREASED 6 0.0013
116 CONCUSSION 10 0.0013
117 MULTIPLE MYELOMA 6 0.0013
118 NEPHROPATHY 12 0.0013
119 YELLOW SKIN 6 0.0013
120 EPIGASTRIC DISCOMFORT 5 0.0013
121 ELECTROCARDIOGRAM ABNORMAL 10 0.0013
122 PHARMACEUTICAL PRODUCT COMPLAINT 33 0.0013
123 ABDOMINAL ADHESIONS 4 0.0013
124 HYPERLIPIDAEMIA 15 0.0013
125 CHRONIC KIDNEY DISEASE 95 0.0012
126 ANGIOPATHY 7 0.0012
127 FAECAL INCONTINENCE 6 0.0012
128 TRIGEMINAL NEURALGIA 5 0.0012
129 HEART RATE IRREGULAR 28 0.0012
130 CARDIAC FLUTTER 8 0.0012
131 MUSCLE DISORDER 10 0.0012
132 PERIPHERAL ISCHAEMIA 5 0.0012
133 POLYURIA 10 0.0012
134 CARDIOMEGALY 15 0.0012
135 WALKING AID USER 8 0.0012
136 VENTRICULAR TACHYCARDIA 20 0.0012
137 SEASONAL ALLERGY 17 0.0012
138 CONGESTIVE CARDIOMYOPATHY 5 0.0012
139 VEIN DISORDER 6 0.0012
140 HYPOKALAEMIA 55 0.0012
141 ECONOMIC PROBLEM 18 0.0012
142 ENERGY INCREASED 7 0.0012
143 CARDIAC PACEMAKER INSERTION 7 0.0012
144 FLANK PAIN 11 0.0012
145 CARBOHYDRATE ANTIGEN 125 INCREASED 4 0.0012
146 INJECTION SITE HAEMATOMA 17 0.0012
147 PROTHROMBIN TIME PROLONGED 7 0.0012
148 GOUT 21 0.0012
149 LACERATION 11 0.0012
150 APLASIA PURE RED CELL 4 0.0012
151 METASTATIC NEOPLASM 5 0.0012
152 LYMPHOEDEMA 8 0.0012
153 OSTEOARTHRITIS 49 0.0012
154 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
155 CHOLECYSTECTOMY 13 0.0011
156 FACIAL PARESIS 4 0.0011
157 PHARYNGOLARYNGEAL PAIN 6 0.0011
158 OBSESSIVE-COMPULSIVE DISORDER 9 0.0011
159 MADAROSIS 13 0.0011
160 COMPRESSION FRACTURE 6 0.0011
161 FRUSTRATION 4 0.0011
162 INFUSION SITE SWELLING 7 0.0011
163 CHEILITIS 6 0.0011
164 VISUAL FIELD DEFECT 8 0.0011
165 BLOOD THYROID STIMULATING HORMONE DECREASED 5 0.0011
166 BLOOD IRON DECREASED 13 0.0011
167 UTERINE LEIOMYOMA 8 0.0011
168 ARTHROPOD BITE 8 0.0011
169 DRY MOUTH 87 0.0011
170 REFUSAL OF TREATMENT BY PATIENT 7 0.0011
171 NOCTURIA 13 0.0011
172 FIBROMYALGIA 26 0.0011
173 INFUSION SITE ERYTHEMA 9 0.0011
174 OBESITY 17 0.0011
175 VAGINAL INFECTION 5 0.0011
176 CORONARY ARTERY DISEASE 32 0.0011
177 MYOCARDIAL ISCHAEMIA 12 0.0011
178 FACE INJURY 4 0.0011
179 CHOLECYSTITIS CHRONIC 7 0.0010
180 BLOOD MAGNESIUM DECREASED 9 0.0010
181 PHARYNGEAL OEDEMA 16 0.0010
182 ULCER HAEMORRHAGE 7 0.0010
183 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
184 SKIN WARM 6 0.0010
185 BODY HEIGHT DECREASED 11 0.0010
186 FAECES HARD 4 0.0010
187 BLOOD CALCIUM INCREASED 9 0.0010
188 RENAL CELL CARCINOMA 5 0.0010
189 RENAL TUBULAR NECROSIS 10 0.0010
190 JOINT EFFUSION 7 0.0010
191 HEPARIN-INDUCED THROMBOCYTOPENIA 5 0.0010
192 CATARACT OPERATION 6 0.0010
193 FURUNCLE 8 0.0010
194 CEREBRAL ATROPHY 4 0.0010
195 LOW TURNOVER OSTEOPATHY 4 0.0010
196 CARPAL TUNNEL SYNDROME 14 0.0010
197 FLUID INTAKE REDUCED 5 0.0010
198 KNEE ARTHROPLASTY 21 0.0010
199 CORONARY ARTERY STENOSIS 5 0.0010
200 RESTLESS LEGS SYNDROME 18 0.0010
201 THERMAL BURN 7 0.0010
202 DRY THROAT 10 0.0010
203 INITIAL INSOMNIA 10 0.0010
204 PARAESTHESIA ORAL 14 0.0010
205 LIMB DISCOMFORT 30 0.0010
206 IMPAIRED DRIVING ABILITY 11 0.0010
207 BASAL CELL CARCINOMA 15 0.0010
208 NASAL DRYNESS 6 0.0010
209 MULTIPLE INJURIES 6 0.0010
210 UPPER GASTROINTESTINAL HAEMORRHAGE 16 0.0010
211 FOREIGN BODY SENSATION IN EYES 6 0.0009
212 DEEP VEIN THROMBOSIS 61 0.0009
213 BLOOD CREATININE INCREASED 61 0.0009
214 FOOD POISONING 5 0.0009
215 IRRITABLE BOWEL SYNDROME 20 0.0009
216 ATELECTASIS 9 0.0009
217 ABNORMAL SENSATION IN EYE 4 0.0009
218 MUSCULOSKELETAL DISCOMFORT 16 0.0009
219 HEPATIC LESION 4 0.0009
220 BACK DISORDER 15 0.0009
221 MUSCULOSKELETAL PAIN 48 0.0009
222 SOMNAMBULISM 6 0.0009
223 HYPERKALAEMIA 32 0.0009
224 NONSPECIFIC REACTION 5 0.0009
225 POLLAKIURIA 38 0.0009
226 DYSGRAPHIA 6 0.0009
227 INJURY 64 0.0009
228 SINUS DISORDER 18 0.0009
229 CHOKING SENSATION 5 0.0009
230 BLOOD TRIGLYCERIDES INCREASED 16 0.0009
231 APPETITE DISORDER 6 0.0009
232 FLUSHING 92 0.0009
233 FEELING COLD 25 0.0009
234 FLUID OVERLOAD 13 0.0009
235 MULTIPLE ALLERGIES 7 0.0009
236 DIABETES MELLITUS 68 0.0009
237 TYPE 2 DIABETES MELLITUS 30 0.0009
238 AFFECTIVE DISORDER 7 0.0009
239 DYSPHONIA 52 0.0009
240 POSTOPERATIVE WOUND INFECTION 6 0.0009
241 FLUID RETENTION 45 0.0009
242 MITRAL VALVE INCOMPETENCE 10 0.0009
243 IMPAIRED HEALING 29 0.0009
244 GLAUCOMA 17 0.0009
245 CHOLECYSTITIS ACUTE 5 0.0009
246 RENAL CYST 7 0.0009
247 TRICUSPID VALVE INCOMPETENCE 7 0.0009
248 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
249 ERUCTATION 17 0.0009
250 END STAGE RENAL DISEASE 16 0.0009
251 ABDOMINAL HERNIA 4 0.0009
252 HAEMOGLOBIN INCREASED 4 0.0009
253 NEUROLOGICAL SYMPTOM 5 0.0009
254 PULMONARY EMBOLISM 83 0.0009
255 MOVEMENT DISORDER 28 0.0009
256 MUSCLE SPASMS 160 0.0009
257 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
258 GRAND MAL CONVULSION 8 0.0009
259 BLOOD CHOLESTEROL ABNORMAL 4 0.0009
260 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
261 MENTAL STATUS CHANGES 24 0.0009
262 COORDINATION ABNORMAL 12 0.0009
263 HAEMATOCRIT DECREASED 17 0.0009
264 BALANCE DISORDER 74 0.0009
265 BLOOD PRESSURE ABNORMAL 17 0.0009
266 JOINT DISLOCATION 9 0.0009
267 THERAPEUTIC RESPONSE UNEXPECTED 38 0.0008
268 DIVERTICULUM 6 0.0008
269 CHRONIC LYMPHOCYTIC LEUKAEMIA 4 0.0008
270 JOINT INJURY 18 0.0008
271 GALLBLADDER DISORDER 15 0.0008
272 NIGHT SWEATS 27 0.0008
273 BLOOD PRESSURE INCREASED 128 0.0008
274 HEARING IMPAIRED 5 0.0008
275 OEDEMA 45 0.0008
276 TONGUE DISORDER 6 0.0008
277 INTERVERTEBRAL DISC PROTRUSION 18 0.0008
278 HAEMORRHOIDS 16 0.0008
279 FEAR 22 0.0008
280 BLINDNESS TRANSIENT 6 0.0008
281 FOOT OPERATION 4 0.0008
282 FEELING DRUNK 6 0.0008
283 SCOLIOSIS 5 0.0008
284 ABDOMINAL TENDERNESS 4 0.0008
285 TINNITUS 37 0.0008
286 NECK PAIN 45 0.0008
287 GLOSSODYNIA 18 0.0008
288 ORAL PAIN 18 0.0008
289 MIDDLE INSOMNIA 15 0.0008
290 DEAFNESS 21 0.0008
291 CORONARY ARTERY OCCLUSION 11 0.0008
292 UPPER RESPIRATORY TRACT INFECTION 37 0.0008
293 SALIVARY HYPERSECRETION 8 0.0008
294 LUNG INFILTRATION 7 0.0008
295 RENAL FAILURE 105 0.0008
296 GASTRIC ULCER 15 0.0008
297 CORONARY ARTERIAL STENT INSERTION 4 0.0008
298 PRURITUS GENERALISED 17 0.0008
299 DYSPEPSIA 77 0.0008
300 DEHYDRATION 104 0.0008
301 ARTHRITIS 61 0.0008
302 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
303 GASTROOESOPHAGEAL REFLUX DISEASE 62 0.0008
304 NERVOUSNESS 40 0.0008
305 MUSCULAR WEAKNESS 87 0.0008
306 TOOTH DISORDER 17 0.0008
307 AGEUSIA 19 0.0008
308 INCREASED TENDENCY TO BRUISE 7 0.0008
309 FOOD CRAVING 4 0.0008
310 SCAR 13 0.0008
311 NASAL DISCOMFORT 6 0.0008
312 BLOOD ALBUMIN DECREASED 6 0.0008
313 RENAL PAIN 8 0.0008
314 SINUSITIS 77 0.0008
315 TUBULOINTERSTITIAL NEPHRITIS 14 0.0007
316 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
317 JOINT RANGE OF MOTION DECREASED 10 0.0007
318 SENSORY LOSS 6 0.0007
319 URINARY INCONTINENCE 22 0.0007
320 GINGIVITIS 4 0.0007
321 FLATULENCE 42 0.0007
322 RENAL INJURY 22 0.0007
323 FAECES DISCOLOURED 16 0.0007
324 SWOLLEN TONGUE 23 0.0007
325 CARDIAC FAILURE CONGESTIVE 59 0.0007
326 FAECALOMA 4 0.0007
327 ECCHYMOSIS 5 0.0007
328 SEROTONIN SYNDROME 14 0.0007
329 ASTHENOPIA 4 0.0007
330 DEAFNESS UNILATERAL 4 0.0007
331 ABNORMAL DREAMS 20 0.0007
332 SINUS BRADYCARDIA 7 0.0007
333 DROOLING 5 0.0007
334 ANHEDONIA 19 0.0007
335 LARGE INTESTINE POLYP 5 0.0007
336 GAIT DISTURBANCE 138 0.0007
337 EAR PAIN 14 0.0007
338 RASH PRURITIC 39 0.0007
339 ORAL DISCOMFORT 10 0.0007
340 NERVE INJURY 8 0.0007
341 AUTOIMMUNE HEPATITIS 5 0.0007
342 FORMICATION 5 0.0007
343 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
344 VITAMIN D DEFICIENCY 7 0.0007
345 CONTUSION 69 0.0007
346 EXTRASYSTOLES 5 0.0007
347 COELIAC DISEASE 7 0.0007
348 SKIN INFECTION 8 0.0007
349 TRANSIENT ISCHAEMIC ATTACK 24 0.0007
350 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 37 0.0007
351 EYE INFECTION 8 0.0007
352 EJECTION FRACTION DECREASED 11 0.0007
353 CATARACT 42 0.0007
354 INTRAOCULAR PRESSURE INCREASED 9 0.0007
355 HYPOPHAGIA 18 0.0007
356 RETCHING 15 0.0007
357 GENERALISED ERYTHEMA 4 0.0007
358 BRONCHITIS 52 0.0007
359 VITAMIN D DECREASED 6 0.0007
360 CHOLELITHIASIS 23 0.0007
361 INFUSION SITE PAIN 9 0.0007
362 CARDIAC MURMUR 6 0.0007
363 PANIC REACTION 5 0.0007
364 HYSTERECTOMY 6 0.0007
365 BLOOD URIC ACID INCREASED 4 0.0007
366 VISUAL ACUITY REDUCED 23 0.0007
367 ELECTROLYTE IMBALANCE 8 0.0007
368 WEIGHT DECREASED 192 0.0007
369 JOINT SWELLING 83 0.0007
370 UNEVALUABLE EVENT 52 0.0007
371 BLOOD CHOLESTEROL INCREASED 32 0.0007
372 BEDRIDDEN 9 0.0007
373 TOOTH INFECTION 9 0.0007
374 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
375 RIB FRACTURE 14 0.0007
376 ACUTE MYOCARDIAL INFARCTION 20 0.0007
377 DIABETES MELLITUS INADEQUATE CONTROL 12 0.0007
378 SKIN DISCOLOURATION 31 0.0007
379 VENTRICULAR EXTRASYSTOLES 7 0.0007
380 FACIAL PAIN 6 0.0007
381 PAIN IN JAW 19 0.0007
382 HYPERTENSION 142 0.0007
383 MACULAR DEGENERATION 8 0.0007
384 CONSTIPATION 146 0.0007
385 FEELING HOT 41 0.0007
386 ASTHENIA 251 0.0007
387 HYPOAESTHESIA ORAL 10 0.0007
388 HYPERSOMNIA 19 0.0007
389 LIMB INJURY 18 0.0007
390 SWELLING 62 0.0007
391 PAIN IN EXTREMITY 195 0.0007
392 BLOOD COUNT ABNORMAL 10 0.0007
393 UNRESPONSIVE TO STIMULI 17 0.0007
394 ACUTE HEPATIC FAILURE 9 0.0007
395 SKIN ULCER 17 0.0007
396 TROPONIN INCREASED 5 0.0007
397 PERIPHERAL COLDNESS 9 0.0007
398 BOWEL MOVEMENT IRREGULARITY 5 0.0007
399 BLOOD THYROID STIMULATING HORMONE INCREASED 6 0.0007
400 SKIN CANCER 14 0.0006
401 HEMIPARESIS 11 0.0006
402 HYPOAESTHESIA 97 0.0006
403 HYPERCALCAEMIA 8 0.0006
404 ABASIA 16 0.0006
405 ATRIAL FIBRILLATION 63 0.0006
406 APHONIA 9 0.0006
407 BIPOLAR DISORDER 7 0.0006
408 PRODUCT SUBSTITUTION ISSUE 37 0.0006
409 DIARRHOEA HAEMORRHAGIC 6 0.0006
410 TASTE DISORDER 13 0.0006
411 INJECTION SITE DISCOLOURATION 8 0.0006
412 HAEMORRHAGIC STROKE 5 0.0006
413 DYSKINESIA 26 0.0006
414 DIZZINESS 318 0.0006
415 ARTERIOSCLEROSIS 6 0.0006
416 DEPRESSION 145 0.0006
417 STAPHYLOCOCCAL INFECTION 21 0.0006
418 PERIPHERAL SWELLING 98 0.0006
419 ARTERIAL OCCLUSIVE DISEASE 5 0.0006
420 COMPLETED SUICIDE 53 0.0006
421 RED BLOOD CELL SEDIMENTATION RATE INCREASED 7 0.0006
422 DRUG EFFECT DECREASED 34 0.0006
423 SYNCOPE 63 0.0006
424 RESPIRATORY TRACT CONGESTION 10 0.0006
425 SCIATICA 10 0.0006
426 CHEST DISCOMFORT 64 0.0006
427 COLD SWEAT 11 0.0006
428 ACUTE RESPIRATORY FAILURE 12 0.0006
429 ROTATOR CUFF SYNDROME 8 0.0006
430 FEELING ABNORMAL 149 0.0006
431 STENT PLACEMENT 5 0.0006
432 MYASTHENIA GRAVIS 5 0.0006
433 DIZZINESS POSTURAL 6 0.0006
434 MUSCLE TIGHTNESS 10 0.0006
435 PSORIATIC ARTHROPATHY 25 0.0006
436 BACK PAIN 143 0.0006
437 CHOKING 12 0.0006
438 DERMATITIS CONTACT 7 0.0006
439 PLATELET COUNT INCREASED 8 0.0006
440 DECUBITUS ULCER 5 0.0006
441 DIVERTICULITIS 17 0.0006
442 NODULE 8 0.0006
443 BRADYPHRENIA 4 0.0006
444 ARRHYTHMIA 29 0.0006
445 ABNORMAL FAECES 5 0.0006
446 HOSPICE CARE 6 0.0006
447 VERTIGO 37 0.0006
448 FALL 202 0.0006
449 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
450 LIGAMENT SPRAIN 6 0.0006
451 HEART RATE INCREASED 60 0.0006
452 SPINAL COMPRESSION FRACTURE 5 0.0006
453 COLON CANCER 9 0.0006
454 PARAESTHESIA 95 0.0006
455 ACUTE CORONARY SYNDROME 5 0.0006
456 BONE DISORDER 11 0.0006
457 EYE PAIN 34 0.0006
458 EYELID OEDEMA 7 0.0006
459 EAR INFECTION 16 0.0006
460 VASCULITIS 7 0.0006
461 LIP SWELLING 20 0.0006
462 OVARIAN CYST 6 0.0006
463 MYALGIA 102 0.0006
464 EYE HAEMORRHAGE 8 0.0006
465 COUGH 168 0.0006
466 DYSURIA 22 0.0006
467 INTERNATIONAL NORMALISED RATIO INCREASED 17 0.0006
468 EMPHYSEMA 6 0.0006
469 RED BLOOD CELL COUNT DECREASED 17 0.0006
470 WEIGHT INCREASED 133 0.0006
471 LYMPHADENOPATHY 21 0.0006
472 INSOMNIA 158 0.0006
473 ABDOMINAL PAIN UPPER 122 0.0006
474 EYELID PTOSIS 6 0.0006
475 WHEEZING 35 0.0006
476 TOOTH ABSCESS 6 0.0006
477 DRUG DISPENSING ERROR 9 0.0006
478 NEPHROLITHIASIS 27 0.0006
479 CHOLECYSTITIS 7 0.0006
480 CIRCULATORY COLLAPSE 10 0.0006
481 FACIAL PARALYSIS 5 0.0006
482 EYE MOVEMENT DISORDER 4 0.0006
483 ERECTILE DYSFUNCTION 15 0.0006
484 DYSPNOEA EXERTIONAL 22 0.0006
485 THYROID DISORDER 9 0.0006
486 CHEST PAIN 108 0.0006
487 DYSSTASIA 17 0.0006
488 MUSCULOSKELETAL STIFFNESS 51 0.0006
489 APPLICATION SITE RASH 8 0.0006
490 TEMPERATURE INTOLERANCE 6 0.0006
491 PROSTATIC SPECIFIC ANTIGEN INCREASED 8 0.0006
492 FOOT FRACTURE 11 0.0006
493 THROAT IRRITATION 26 0.0006
494 LOCALISED INFECTION 14 0.0006
495 MULTI-ORGAN FAILURE 10 0.0006
496 WRONG TECHNIQUE IN DRUG USAGE PROCESS 21 0.0006
497 DIPLOPIA 15 0.0006
498 EYE DISCHARGE 6 0.0006
499 FEELING JITTERY 11 0.0006
500 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 41 0.0006
501 LARGE INTESTINE PERFORATION 4 0.0006
502 RESPIRATORY TRACT INFECTION 15 0.0006
503 CHROMATURIA 13 0.0006
504 PRESYNCOPE 14 0.0006
505 VISION BLURRED 79 0.0006
506 ORTHOSTATIC HYPOTENSION 10 0.0006
507 WEIGHT FLUCTUATION 6 0.0006
508 PRODUCT ODOUR ABNORMAL 6 0.0006
509 SPEECH DISORDER 30 0.0006
510 PALPITATIONS 67 0.0006
511 BLOOD PRESSURE DECREASED 38 0.0006
512 DEFAECATION URGENCY 4 0.0006
513 EOSINOPHILIA 10 0.0006
514 BURNING SENSATION 40 0.0006
515 AMNESIA 37 0.0006
516 NEUROPATHY PERIPHERAL 54 0.0006
517 INCONTINENCE 6 0.0006
518 PNEUMOTHORAX 9 0.0006
519 TARDIVE DYSKINESIA 16 0.0006
520 SUDDEN DEATH 6 0.0006
521 CYSTITIS 18 0.0006
522 CYST 7 0.0006
523 BREAST PAIN 6 0.0006
524 SENSORY DISTURBANCE 9 0.0006
525 THROMBOSIS 45 0.0006
526 OSTEOPOROSIS 23 0.0006
527 HEREDITARY ANGIOEDEMA 6 0.0006
528 HALLUCINATION 42 0.0006
529 ABDOMINAL DISTENSION 58 0.0006
530 LEUKOCYTOSIS 10 0.0006
531 MUSCLE ATROPHY 7 0.0006
532 TOOTHACHE 10 0.0006
533 SKIN LACERATION 6 0.0006
534 BACK INJURY 6 0.0006
535 LIP DRY 5 0.0005
536 OPTIC NEURITIS 5 0.0005
537 PULMONARY THROMBOSIS 6 0.0005
538 ROAD TRAFFIC ACCIDENT 23 0.0005
539 OESOPHAGITIS 6 0.0005
540 HYPERGLYCAEMIA 20 0.0005
541 PANIC ATTACK 20 0.0005
542 BONE PAIN 32 0.0005
543 MEMORY IMPAIRMENT 75 0.0005
544 HAEMOGLOBIN DECREASED 56 0.0005
545 PHOTOSENSITIVITY REACTION 9 0.0005
546 BRAIN NEOPLASM 5 0.0005
547 ANGIOEDEMA 24 0.0005
548 IRON DEFICIENCY ANAEMIA 5 0.0005
549 RHINORRHOEA 35 0.0005
550 BLOOD GLUCOSE DECREASED 26 0.0005
551 THINKING ABNORMAL 10 0.0005
552 CELLULITIS 27 0.0005
553 HYPERHIDROSIS 69 0.0005
554 RASH PAPULAR 12 0.0005
555 SNEEZING 12 0.0005
556 EPISTAXIS 40 0.0005
557 OCULAR DISCOMFORT 6 0.0005
558 PAIN 328 0.0005
559 DECREASED APPETITE 124 0.0005
560 URINARY TRACT INFECTION 91 0.0005
561 DYSARTHRIA 20 0.0005
562 LACRIMATION INCREASED 16 0.0005
563 BRADYCARDIA 28 0.0005
564 SPUTUM DISCOLOURED 5 0.0005
565 BLOOD URINE PRESENT 10 0.0005
566 TREMOR 87 0.0005
567 ANXIETY 149 0.0005
568 CRYING 19 0.0005
569 LIPASE INCREASED 4 0.0005
570 POST PROCEDURAL COMPLICATION 10 0.0005
571 MUSCLE TWITCHING 12 0.0005
572 AFFECT LABILITY 5 0.0005
573 FOOD ALLERGY 4 0.0005
574 HERNIA 10 0.0005
575 NAUSEA 409 0.0005
576 FATIGUE 402 0.0005
577 DYSPHAGIA 49 0.0005
578 ACUTE KIDNEY INJURY 79 0.0005
579 DYSPNOEA 290 0.0005
580 PHARYNGEAL SWELLING 5 0.0005
581 PRURITUS 196 0.0005
582 VITREOUS FLOATERS 5 0.0005
583 THERAPY CHANGE 5 0.0005
584 LABORATORY TEST ABNORMAL 15 0.0005
585 THERAPY CESSATION 26 0.0005
586 ATAXIA 6 0.0005
587 HERPES ZOSTER 29 0.0005
588 HOT FLUSH 38 0.0005
589 INABILITY TO AFFORD MEDICATION 5 0.0005
590 RASH GENERALISED 13 0.0005
591 SOMNOLENCE 101 0.0005
592 ATRIAL FLUTTER 4 0.0005
593 MOBILITY DECREASED 36 0.0005
594 RENAL IMPAIRMENT 42 0.0005
595 DIABETIC KETOACIDOSIS 12 0.0005
596 SPINAL FRACTURE 10 0.0005
597 BLOOD TEST ABNORMAL 7 0.0005
598 APHASIA 15 0.0005
599 FULL BLOOD COUNT DECREASED 10 0.0005
600 WHITE BLOOD CELL COUNT INCREASED 19 0.0005
601 GASTRITIS 13 0.0005
602 ALOPECIA 97 0.0005
603 ARTHRALGIA 205 0.0005
604 NO THERAPEUTIC RESPONSE 6 0.0005
605 PANCREATITIS 26 0.0005
606 MOTOR DYSFUNCTION 5 0.0005
607 SLUGGISHNESS 5 0.0005
608 SUBDURAL HAEMATOMA 7 0.0005
609 SPINAL OPERATION 6 0.0005
610 LETHARGY 28 0.0005
611 TENDON RUPTURE 6 0.0005
612 DYSGEUSIA 36 0.0005
613 FEMUR FRACTURE 15 0.0005
614 EYE SWELLING 18 0.0005
615 HYPERTHYROIDISM 7 0.0005
616 DIARRHOEA 312 0.0005
617 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
618 SLEEP DISORDER 34 0.0005
619 CARDIAC DISORDER 45 0.0005
620 EOSINOPHIL COUNT INCREASED 4 0.0005
621 APATHY 7 0.0005
622 SKIN DISORDER 16 0.0005
623 STOMATITIS 29 0.0005
624 ILL-DEFINED DISORDER 29 0.0005
625 NASAL CONGESTION 28 0.0005
626 GLYCOSYLATED HAEMOGLOBIN INCREASED 12 0.0005
627 OROPHARYNGEAL PAIN 44 0.0005
628 HEAD INJURY 15 0.0005
629 CARDIOMYOPATHY 7 0.0005
630 HALLUCINATION, VISUAL 10 0.0005
631 HAEMATEMESIS 12 0.0005
632 SKIN HAEMORRHAGE 7 0.0005
633 CONVULSION 27 0.0005
634 RESPIRATORY ARREST 13 0.0005
635 ABDOMINAL DISCOMFORT 79 0.0005
636 INADEQUATE ANALGESIA 4 0.0005
637 EMOTIONAL DISTRESS 57 0.0005
638 PULMONARY MASS 7 0.0005
639 DRUG EFFECT INCOMPLETE 17 0.0005
640 HEADACHE 293 0.0005
641 ANURIA 4 0.0005
642 PARANOIA 8 0.0005
643 PRODUCT QUALITY ISSUE 63 0.0005
644 DECREASED ACTIVITY 5 0.0005
645 HYPERSENSITIVITY 86 0.0005
646 BLISTER 26 0.0005
647 NIGHTMARE 16 0.0005
648 INCORRECT DRUG ADMINISTRATION DURATION 13 0.0005
649 INFLUENZA LIKE ILLNESS 38 0.0005
650 ASTHMA 52 0.0005
651 MENTAL DISORDER 20 0.0005
652 PRODUCT DISPENSING ERROR 10 0.0005
653 MYOCARDIAL INFARCTION 80 0.0005
654 CONFUSIONAL STATE 74 0.0005
655 METASTASES TO LIVER 8 0.0005
656 INJECTION SITE NODULE 5 0.0005
657 ANKLE FRACTURE 7 0.0005
658 DENTAL CARIES 5 0.0005
659 HEAD DISCOMFORT 8 0.0005
660 PSORIASIS 59 0.0005
661 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
662 PRESCRIBED UNDERDOSE 9 0.0005
663 ANAEMIA 86 0.0005
664 CEREBROVASCULAR ACCIDENT 76 0.0004
665 MALIGNANT MELANOMA 6 0.0004
666 BRAIN FOG 7 0.0004
667 SWELLING FACE 29 0.0004
668 CYANOSIS 7 0.0004
669 PANCREATITIS ACUTE 10 0.0004
670 BLOOD CALCIUM DECREASED 5 0.0004
671 SINUS CONGESTION 6 0.0004
672 RECTAL HAEMORRHAGE 19 0.0004
673 BLOOD GLUCOSE INCREASED 83 0.0004
674 DRUG TOXICITY 6 0.0004
675 MULTIPLE SCLEROSIS 21 0.0004
676 ABSCESS 7 0.0004
677 HYPOTENSION 88 0.0004
678 LOSS OF CONSCIOUSNESS 56 0.0004
679 PULMONARY HYPERTENSION 9 0.0004
680 HUNGER 6 0.0004
681 CARDIO-RESPIRATORY ARREST 18 0.0004
682 TACHYCARDIA 38 0.0004
683 HEART RATE DECREASED 15 0.0004
684 SPLENOMEGALY 5 0.0004
685 BLINDNESS UNILATERAL 6 0.0004
686 PHOTOPHOBIA 8 0.0004
687 CONDITION AGGRAVATED 129 0.0004
688 NASOPHARYNGITIS 78 0.0004
689 PROTEINURIA 8 0.0004
690 MUSCULOSKELETAL DISORDER 8 0.0004
691 SEDATION 11 0.0004
692 ERYTHEMA 86 0.0004
693 POLYNEUROPATHY 5 0.0004
694 BLOOD PRESSURE FLUCTUATION 10 0.0004
695 THYROID CANCER 5 0.0004
696 HYPERCHOLESTEROLAEMIA 4 0.0004
697 HYPOKINESIA 6 0.0004
698 GASTROENTERITIS 6 0.0004
699 AGITATION 30 0.0004
700 RASH 178 0.0004
701 GASTRIC DISORDER 14 0.0004
702 INFLAMMATION 21 0.0004
703 COGNITIVE DISORDER 19 0.0004
704 GASTROINTESTINAL HAEMORRHAGE 34 0.0004
705 KNEE OPERATION 4 0.0004
706 SMALL INTESTINAL OBSTRUCTION 5 0.0004
707 PALLOR 11 0.0004
708 HIP FRACTURE 13 0.0004
709 VOMITING 190 0.0004
710 DISORIENTATION 16 0.0004
711 PHARYNGITIS 5 0.0004
712 EXTRAPYRAMIDAL DISORDER 10 0.0004
713 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
714 PULMONARY OEDEMA 18 0.0004
715 SKIN LESION 11 0.0004
716 CHILLS 47 0.0004
717 DRY EYE 20 0.0004
718 EYE IRRITATION 23 0.0004
719 DISEASE RECURRENCE 19 0.0004
720 SECRETION DISCHARGE 5 0.0004
721 PNEUMONIA 129 0.0004
722 POISONING 5 0.0004
723 DERMATITIS ALLERGIC 5 0.0004
724 RASH ERYTHEMATOUS 19 0.0004
725 RHEUMATOID ARTHRITIS 45 0.0004
726 HEPATIC ENZYME INCREASED 27 0.0004
727 ARTHROPATHY 22 0.0004
728 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
729 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
730 HYPOACUSIS 17 0.0004
731 MALAISE 173 0.0004
732 HAEMOPTYSIS 11 0.0004
733 WOUND 11 0.0004
734 DRUG DOSE OMISSION 65 0.0004
735 INSURANCE ISSUE 6 0.0004
736 BODY TEMPERATURE INCREASED 8 0.0004
737 GASTROENTERITIS VIRAL 7 0.0004
738 CARDIAC ARREST 32 0.0004
739 TENDONITIS 6 0.0004
740 PLATELET COUNT DECREASED 41 0.0004
741 RESPIRATORY FAILURE 28 0.0004
742 INTENTIONAL DRUG MISUSE 8 0.0004
743 DERMATITIS 8 0.0004
744 FOLLICULITIS 4 0.0004
745 THERAPEUTIC RESPONSE DECREASED 23 0.0004
746 VISUAL IMPAIRMENT 47 0.0004
747 DRUG INTERACTION 60 0.0004
748 PLEURAL EFFUSION 23 0.0004
749 HALLUCINATION, AUDITORY 6 0.0004
750 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
751 ULCER 6 0.0004
752 HEPATIC STEATOSIS 7 0.0004
753 IMPAIRED WORK ABILITY 8 0.0004
754 OXYGEN SATURATION DECREASED 21 0.0004
755 BREAST CANCER METASTATIC 4 0.0004
756 RASH MACULAR 13 0.0004
757 FREQUENT BOWEL MOVEMENTS 10 0.0004
758 HYPOCALCAEMIA 7 0.0004
759 THROAT TIGHTNESS 10 0.0004
760 BLOOD POTASSIUM INCREASED 6 0.0004
761 PRODUCT TASTE ABNORMAL 5 0.0004
762 PRODUCT DOSE OMISSION 24 0.0004
763 LUNG DISORDER 18 0.0004
764 ABDOMINAL PAIN 85 0.0004
765 BLOOD GLUCOSE FLUCTUATION 4 0.0004
766 PULMONARY FIBROSIS 7 0.0004
767 LOWER LIMB FRACTURE 7 0.0004
768 DRUG LEVEL INCREASED 6 0.0004
769 EXPIRED PRODUCT ADMINISTERED 12 0.0004
770 COAGULOPATHY 6 0.0004
771 URINARY RETENTION 12 0.0004
772 HYPERTENSIVE CRISIS 4 0.0004
773 SURGERY 21 0.0004
774 SKIN FISSURES 7 0.0004
775 URTICARIA 60 0.0004
776 ASPARTATE AMINOTRANSFERASE INCREASED 19 0.0004
777 EMOTIONAL DISORDER 11 0.0004
778 DEVICE OCCLUSION 5 0.0004
779 ABNORMAL BEHAVIOUR 14 0.0004
780 APPLICATION SITE PRURITUS 8 0.0004
781 DIALYSIS 5 0.0004
782 UPPER LIMB FRACTURE 7 0.0004
783 HAEMATURIA 12 0.0004
784 IMPAIRED QUALITY OF LIFE 5 0.0003
785 GASTRIC HAEMORRHAGE 4 0.0003
786 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 19 0.0003
787 FEEDING DISORDER 7 0.0003
788 INTESTINAL OBSTRUCTION 13 0.0003
789 DRY SKIN 46 0.0003
790 HYPOTHYROIDISM 11 0.0003
791 APPLICATION SITE ERYTHEMA 9 0.0003
792 JOINT STIFFNESS 9 0.0003
793 INFLUENZA 38 0.0003
794 TOOTH LOSS 7 0.0003
795 ACCIDENT 4 0.0003
796 OSTEONECROSIS 11 0.0003
797 HAEMORRHAGE INTRACRANIAL 5 0.0003
798 IRRITABILITY 20 0.0003
799 SKIN EXFOLIATION 28 0.0003
800 HEPATITIS C 4 0.0003
801 MENTAL IMPAIRMENT 8 0.0003
802 FUNGAL INFECTION 11 0.0003
803 HYPOGLYCAEMIA 16 0.0003
804 NEURALGIA 8 0.0003
805 EATING DISORDER 7 0.0003
806 EYE PRURITUS 11 0.0003
807 CONJUNCTIVITIS 6 0.0003
808 GENERALISED OEDEMA 4 0.0003
809 VAGINAL HAEMORRHAGE 14 0.0003
810 RENAL DISORDER 15 0.0003
811 MELAENA 7 0.0003
812 PRODUCT USE COMPLAINT 5 0.0003
813 FRACTURE 6 0.0003
814 ABDOMINAL PAIN LOWER 8 0.0003
815 OCULAR HYPERAEMIA 15 0.0003
816 MIGRAINE 30 0.0003
817 ANGINA PECTORIS 9 0.0003
818 INCREASED APPETITE 6 0.0003
819 WHITE BLOOD CELL COUNT DECREASED 34 0.0003
820 DRUG INEFFECTIVE 412 0.0003
821 HAEMATOMA 8 0.0003
822 DRUG WITHDRAWAL SYNDROME 27 0.0003
823 CEREBRAL HAEMORRHAGE 11 0.0003
824 MULTIPLE SCLEROSIS RELAPSE 21 0.0003
825 KIDNEY INFECTION 6 0.0003
826 HAND DEFORMITY 4 0.0003
827 MANIA 5 0.0003
828 IMMUNE SYSTEM DISORDER 4 0.0003
829 DISABILITY 6 0.0003
830 ADVERSE REACTION 4 0.0003
831 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
832 BREAST CANCER FEMALE 8 0.0003
833 PRODUCT DOSE OMISSION ISSUE 88 0.0003
834 DISEASE PROGRESSION 35 0.0003
835 INJURY ASSOCIATED WITH DEVICE 6 0.0003
836 BLINDNESS 12 0.0003
837 PRODUCTIVE COUGH 14 0.0003
838 GINGIVAL BLEEDING 4 0.0003
839 TREATMENT NONCOMPLIANCE 16 0.0003
840 INFECTION 42 0.0003
841 COLITIS 11 0.0003
842 THERAPY NON-RESPONDER 13 0.0003
843 PROCEDURAL PAIN 8 0.0003
844 INJECTION SITE HAEMORRHAGE 23 0.0003
845 HYPOMAGNESAEMIA 4 0.0003
846 INFUSION RELATED REACTION 19 0.0003
847 INJECTION SITE URTICARIA 7 0.0003
848 ENCEPHALOPATHY 7 0.0003
849 SUICIDAL IDEATION 26 0.0003
850 INJECTION SITE PRURITUS 19 0.0003
851 INJECTION SITE PAIN 87 0.0003
852 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
853 MOOD SWINGS 9 0.0003
854 DISTURBANCE IN ATTENTION 15 0.0003
855 LACTIC ACIDOSIS 9 0.0003
856 ALANINE AMINOTRANSFERASE INCREASED 17 0.0003
857 LIVER FUNCTION TEST ABNORMAL 8 0.0003
858 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
859 INJECTION SITE ERYTHEMA 34 0.0003
860 HEPATITIS 7 0.0003
861 APPLICATION SITE PAIN 6 0.0003
862 BLOOD GLUCOSE ABNORMAL 5 0.0003
863 EXPOSURE VIA SKIN CONTACT 7 0.0003
864 STEVENS-JOHNSON SYNDROME 6 0.0003
865 RASH MACULO-PAPULAR 6 0.0003
866 DRUG INTOLERANCE 26 0.0003
867 IMMUNODEFICIENCY 4 0.0003
868 BACTERIAL INFECTION 5 0.0003
869 COVID-19 47 0.0003
870 ECZEMA 14 0.0003
871 RESPIRATORY DISORDER 8 0.0003
872 DEPRESSED MOOD 14 0.0003
873 INJECTION SITE BRUISING 21 0.0003
874 DEVICE FAILURE 4 0.0003
875 WITHDRAWAL SYNDROME 11 0.0003
876 INJECTION SITE SWELLING 20 0.0003
877 SHOCK 6 0.0003
878 DRUG ADMINISTRATION ERROR 8 0.0003
879 ADVERSE EVENT 24 0.0003
880 UNDERDOSE 19 0.0003
881 PAIN OF SKIN 7 0.0003
882 BLOOD BILIRUBIN INCREASED 7 0.0003
883 HAEMORRHAGE 27 0.0003
884 DELUSION 4 0.0003
885 GASTROINTESTINAL DISORDER 23 0.0003
886 NERVOUS SYSTEM DISORDER 8 0.0003
887 ORAL HERPES 5 0.0003
888 HAEMATOCHEZIA 14 0.0003
889 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
890 PRODUCT ADHESION ISSUE 9 0.0003
891 INTENTIONAL PRODUCT MISUSE 22 0.0003
892 SKIN BURNING SENSATION 18 0.0003
893 DEMENTIA 7 0.0003
894 PYREXIA 86 0.0002
895 DISCOMFORT 15 0.0002
896 SEPSIS 27 0.0002
897 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
898 VIRAL INFECTION 8 0.0002
899 PNEUMONIA ASPIRATION 6 0.0002
900 GAIT INABILITY 8 0.0002
901 ASCITES 7 0.0002
902 MOUTH ULCERATION 5 0.0002
903 FACE OEDEMA 4 0.0002
904 CARDIOVASCULAR DISORDER 6 0.0002
905 MEDICATION ERROR 13 0.0002
906 INJECTION SITE REACTION 16 0.0002
907 HEPATIC FAILURE 7 0.0002
908 LOCAL SWELLING 4 0.0002
909 MUCOSAL INFLAMMATION 6 0.0002
910 DERMATITIS ATOPIC 12 0.0002
911 HYPOXIA 8 0.0002
912 LYMPHOCYTE COUNT DECREASED 4 0.0002
913 ISCHAEMIC STROKE 4 0.0002
914 ILLNESS 23 0.0002
915 JAUNDICE 6 0.0002
916 PNEUMONITIS 6 0.0002
917 RESTLESSNESS 8 0.0002
918 RESPIRATORY DISTRESS 6 0.0002
919 SEIZURE 25 0.0002
920 INJECTION SITE MASS 8 0.0002
921 PERICARDIAL EFFUSION 5 0.0002
922 GENERAL PHYSICAL HEALTH DETERIORATION 25 0.0002
923 INCORRECT DOSE ADMINISTERED 49 0.0002
924 BREAST CANCER 20 0.0002
925 EYE DISORDER 7 0.0002
926 HEPATIC CIRRHOSIS 4 0.0002
927 PRODUCT USE ISSUE 40 0.0002
928 DRUG PRESCRIBING ERROR 4 0.0002
929 NEEDLE ISSUE 6 0.0002
930 INTENTIONAL PRODUCT USE ISSUE 18 0.0002
931 CEREBRAL INFARCTION 5 0.0002
932 PSYCHOTIC DISORDER 6 0.0002
933 INTENTIONAL OVERDOSE 13 0.0002
934 NEOPLASM PROGRESSION 7 0.0002
935 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
936 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
937 THROMBOCYTOPENIA 22 0.0002
938 SKIN IRRITATION 9 0.0002
939 NEUTROPHIL COUNT DECREASED 8 0.0002
940 DEVICE ISSUE 17 0.0002
941 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 38 0.0002
942 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
943 MALIGNANT NEOPLASM PROGRESSION 19 0.0002
944 DEVICE MALFUNCTION 13 0.0002
945 LEUKOPENIA 9 0.0002
946 PANCYTOPENIA 10 0.0002
947 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
948 LUNG NEOPLASM MALIGNANT 7 0.0002
949 THERAPY INTERRUPTED 12 0.0002
950 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
951 NEOPLASM MALIGNANT 11 0.0002
952 INJECTION SITE RASH 5 0.0002
953 ANAPHYLACTIC REACTION 9 0.0002
954 PROSTATE CANCER 13 0.0002
955 OFF LABEL USE 141 0.0002
956 SEPTIC SHOCK 7 0.0002
957 BONE DENSITY DECREASED 5 0.0002
958 LIVER DISORDER 7 0.0002
959 HOSPITALISATION 24 0.0002
960 TOXICITY TO VARIOUS AGENTS 26 0.0002
961 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
962 FEBRILE NEUTROPENIA 10 0.0002
963 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 27 0.0001
964 EXTRA DOSE ADMINISTERED 6 0.0001
965 ANGER 5 0.0001
966 DELIRIUM 5 0.0001
967 RHABDOMYOLYSIS 6 0.0001
968 INTENTIONAL DOSE OMISSION 4 0.0001
969 NO ADVERSE EVENT 25 0.0001
970 C-REACTIVE PROTEIN INCREASED 5 0.0001
971 ACCIDENTAL OVERDOSE 5 0.0001
972 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
973 COLITIS ULCERATIVE 6 0.0001
974 ADVERSE DRUG REACTION 12 0.0001
975 DEATH 115 0.0001
976 PRODUCT USE IN UNAPPROVED INDICATION 33 0.0001
977 ACNE 10 0.0001
978 COMA 6 0.0001
979 CARDIAC FAILURE 10 0.0001
980 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
981 NEUTROPENIA 16 0.0001
982 SUICIDE ATTEMPT 7 0.0001
983 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
984 DEPENDENCE 6 0.0001
985 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
986 RENAL CANCER 5 0.0001
987 AGGRESSION 5 0.0001
988 DEVICE BREAKAGE 4 0.0001
989 OVERDOSE 20 0.0001
990 DEVICE DIFFICULT TO USE 5 0.0001
991 DRUG DEPENDENCE 5 0.0000